Rate My Professor Charlotte Bevan

Bevan's scholarly impact is evidenced by her highly cited publications, including 'The AF1 and AF2 domains of the androgen receptor interact with distinct regions of SRC1' (1999, 544 citations), 'The role of androgen receptor mutations in prostate cancer progression' (2009, 240 citations), 'Prostate cancer cell malignancy via modulation of HIF-1α pathway with isoflurane and propofol alone and in combination' (2014, 276 citations), 'Impact of analytical bias in metabonomic studies of human blood serum and plasma' (2006, 323 citations), and 'Single-molecule amplification-free multiplexed detection of circulating microRNA cancer biomarkers from serum' (2021, 233 citations). She has secured substantial research funding, such as £1.3 million from Prostate Cancer UK and Transformational Impact Awards. Career appointments include Consul for the Faculty of Medicine (non-clinical), member of the Institute of Chemical Biology Executive Board, and Clinical Training Subcommittee at the Convergence Science Centre. Professional contributions feature roles as Honorary Secretary of the British Association for Cancer Research, editorial board member for Endocrine Oncology, and recipient of the 2023 Culture and Community award. She has delivered public lectures, including at the Imperial Science Café on prostate cancer research.